How Orange Book Antitrust Scrutiny is Intensifying

How Orange Book Antitrust Scrutiny is Intensifying | PDF

Administration added an Orange Book dispute listing update to its online repository. ... filing of targeted amicus briefs in high-stakes ...

How Orange Book Antitrust Scrutiny is Intensifying | McDermott

According to the Federal Trade Commission, improperly listing patents in the Orange Book constitutes an unfair method of competition, among ...

How Orange Book Antitrust Scrutiny Is Intensifying - PYMNTS.com

Pharmaceutical patent holders take note: Antitrust enforcers have intensified scrutiny of Orange Book listings...

How Orange Book Antitrust Scrutiny Is Intensifying - Law360

Law360 (July 29, 2024, 1:44 PM EDT) -- Pharmaceutical patent holders beware: Over the past year, antitrust enforcers have taken a more ...

How Orange Book Antitrust Scrutiny Is Intensifying

According to the Federal Trade Commission, improperly listing patents in the Orange Book constitutes an unfair method of competition, among ...

IP Antitrust Archives - ANTITRUST ALERT

How Orange Book Antitrust Scrutiny Is Intensifying · Elai Katz, Lisa P. Rumin and Betty Zhang ; Annual European Competition Review 2021 ; Federal Circuit Lacks ...

An Antitrust Economist's Perspective on Recent FTC Scrutiny ...

However, the relative benefits and costs of listing additional patents may change as the FTC now scrutinizes Orange Book listings to identify ...

Increased Scrutiny by Federal Trade Commission of Orange Book ...

The increased scrutiny by the FTC has led to a rise in antitrust litigation filed by private entities, alleging improper patent listings and monopolization.

US FTC Continues Aggressive Scrutiny of Pharmaceutical Patents ...

FTC Continues to Ramp Up Scrutiny of Orange Book Patent Listings ... These patent listing challenges are just the latest step by the FTC, which ...

Teva Loses Inhaler Patent Case Against Amneal, Must Update ...

The antitrust regulator initiated its scrutiny in November 2023, challenging over 100 patents from companies including AbbVie, GSK, and Teva.

Increased Scrutiny by Federal Trade Commission of Orange Book ...

Conversely, the FTC can serve as an ally for generic manufacturers in delisting and/or antitrust claims. Generic manufacturers can leverage FTC ...

Global antitrust in 2024 - Freshfields

For example, Japanese investors have become subject to intensifying scrutiny due to their ... FTC challenges to Orange Book patent listings under the Food and ...

FTC's watchdog role in pharma mergers: Road bumps and the way ...

On April 30, 2024, the FTC publicly declared its formal challenge of more than 300 patent entries in the FDA's Orange Book and dispatched warning letters to ten ...

U.S. elections and Antitrust : Is the past prologue? - Concurrences

In general, renewed enforcement of the Robinson-Patman Act in the grocery and drug spaces and other efforts to provide a profit floor to small ...

Remarks | Federal Trade Commission

The listing of patents in the Orange Book raises the issue of whether such listings are protected under the Noerr-Pennington doctrine. The Commission filed an ...

Insufficient Mechanisms for Orange Book Corrections and the FDA's ...

Statements: A Response to Terry Mahn's Is It Time for FDA to Revise Its Orange Book Rules to Deal with “Skinny-Labeled” Generic Drugs?, 1 FOOD & DRUG POL'Y F., ...

The Role of Regulatory Agencies and Intellectual Property: Part II

Settlement of such litigation has been identified by the Federal Trade Commission (FTC), and private parties encouraged by the FTC's position, as an antitrust ...

US FTC Targets Pharma Patent Abuse: What You Need to Know

Indeed, the FTC has succeeded in persuading three pharmaceutical companies to remove patents listed in the Orange Book, a registry that is ...

Pharmaceutical Intellectual Property and Competition Law Review

... orange-book. (the Orange Book). 14. 21 USC Section 355(c)(3)(E)(ii), (j)(5)(F ... antitrust scrutiny because they may harm competition by delaying the entry of ...

Pharmaceutical Intellectual Property and Competition: USA - Lexology

It also provides an overview of how these processes and associated strategies may come under antitrust scrutiny. Overall, the complex US legal ...